In one study, what was the accuracy of cytology vs histopath for distinguishing benign vs malignant bone disease and tumor types?

• A. Cytology 83% vs Histology 82% for distinguishing benign vs malignant; tumor type identified in 50% cytology and 55% histology
• B. Cytology 90% vs Histology 85% for distinguishing benign vs malignant; tumor type identified in 70% cytology and 60% histology
• C. Cytology 75% vs Histology 70% for distinguishing benign vs malignant; tumor type identified in 40% cytology and 50% histology
• D. Cytology 60% vs Histology 65% for distinguishing benign vs malignant; tumor type identified in 30% cytology and 35% histology

Answer: (A)

When evaluating bone lesions, how well cytology compares to histopathology for two goals—distinguishing benign from malignant disease and identifying the tumor type—tells you how much confidence to place in less invasive sampling versus full tissue biopsy. In this study, cytology performed about as well as histology for separating benign from malignant bone disease. The difference between the two methods in this task was small, so cytology can be a useful rapid assessment when a full biopsy isn’t immediately feasible. For determining the tumor type, both methods were more limited, but histology offered a modest advantage, likely because preserving tissue architecture helps differentiate subtypes that cytology, which focuses on individual cells, may not distinguish as reliably. This aligns with the idea that cellular samples can diagnose malignancy with reasonable accuracy, but the architectural context of histology provides added clarity for tumor classification. The other scenarios imply larger disparities or greater typing accuracy with one method than what the study reported, which is why this balance—similar accuracy for malignancy discrimination and a slight edge for histology in typing—is the best match.